Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Database
Type of study
Language
Publication year range
1.
J Proteome Res ; 20(7): 3414-3427, 2021 07 02.
Article in English | MEDLINE | ID: mdl-34087075

ABSTRACT

The spindle assembly checkpoint (SAC) is critical for sensing defective microtubule-kinetochore attachments and tension across the kinetochore and functions to arrest cells in prometaphase to allow time to repair any errors before proceeding into anaphase. Dysregulation of the SAC leads to chromosome segregation errors that have been linked to human diseases like cancer. Although much has been learned about the composition of the SAC and the factors that regulate its activity, the proximity associations of core SAC components have not been explored in a systematic manner. Here, we have taken a BioID2-proximity-labeling proteomic approach to define the proximity protein environment for each of the five core SAC proteins BUB1, BUB3, BUBR1, MAD1L1, and MAD2L1 in mitotic-enriched populations of cells where the SAC is active. These five protein association maps were integrated to generate a SAC proximity protein network that contains multiple layers of information related to core SAC protein complexes, protein-protein interactions, and proximity associations. Our analysis validated many known SAC complexes and protein-protein interactions. Additionally, it uncovered new protein associations, including the ELYS-MAD1L1 interaction that we have validated, which lend insight into the functioning of core SAC proteins and highlight future areas of investigation to better understand the SAC.


Subject(s)
M Phase Cell Cycle Checkpoints , Spindle Apparatus , Cell Cycle Proteins/genetics , Humans , Kinetochores , Protein Serine-Threonine Kinases/genetics , Proteomics
2.
J Cell Biol ; 214(2): 143-53, 2016 07 18.
Article in English | MEDLINE | ID: mdl-27432896

ABSTRACT

Precise regulation of centrosome number is critical for accurate chromosome segregation and the maintenance of genomic integrity. In nontransformed cells, centrosome loss triggers a p53-dependent surveillance pathway that protects against genome instability by blocking cell growth. However, the mechanism by which p53 is activated in response to centrosome loss remains unknown. Here, we have used genome-wide CRISPR/Cas9 knockout screens to identify a USP28-53BP1-p53-p21 signaling axis at the core of the centrosome surveillance pathway. We show that USP28 and 53BP1 act to stabilize p53 after centrosome loss and demonstrate this function to be independent of their previously characterized role in the DNA damage response. Surprisingly, the USP28-53BP1-p53-p21 signaling pathway is also required to arrest cell growth after a prolonged prometaphase. We therefore propose that centrosome loss or a prolonged mitosis activate a common signaling pathway that acts to prevent the growth of cells that have an increased propensity for mitotic errors.


Subject(s)
Centrosome/metabolism , Cyclin-Dependent Kinase Inhibitor p21/metabolism , Mitosis , Signal Transduction , Tumor Suppressor Protein p53/metabolism , Tumor Suppressor p53-Binding Protein 1/metabolism , Ubiquitin Thiolesterase/metabolism , Base Sequence , CRISPR-Cas Systems , Cell Cycle Checkpoints , Cell Line , Cell Proliferation , DNA Damage , Gene Knockout Techniques , Humans , Metaphase , Protein Stability
3.
J Cell Biol ; 210(1): 63-77, 2015 Jul 06.
Article in English | MEDLINE | ID: mdl-26150389

ABSTRACT

Centriole function has been difficult to study because of a lack of specific tools that allow persistent and reversible centriole depletion. Here we combined gene targeting with an auxin-inducible degradation system to achieve rapid, titratable, and reversible control of Polo-like kinase 4 (Plk4), a master regulator of centriole biogenesis. Depletion of Plk4 led to a failure of centriole duplication that produced an irreversible cell cycle arrest within a few divisions. This arrest was not a result of a prolonged mitosis, chromosome segregation errors, or cytokinesis failure. Depleting p53 allowed cells that fail centriole duplication to proliferate indefinitely. Washout of auxin and restoration of endogenous Plk4 levels in cells that lack centrioles led to the penetrant formation of de novo centrioles that gained the ability to organize microtubules and duplicate. In summary, we uncover a p53-dependent surveillance mechanism that protects against genome instability by preventing cell growth after centriole duplication failure.


Subject(s)
Centrioles/genetics , Genomic Instability , Tumor Suppressor Protein p53/physiology , Cell Cycle Checkpoints , Cell Line , Cell Proliferation , Centrioles/physiology , Chromosome Segregation , Humans , Microtubules/metabolism , Mitosis , Protein Serine-Threonine Kinases/physiology , Protein Transport
4.
J Cell Biol ; 209(6): 863-78, 2015 Jun 22.
Article in English | MEDLINE | ID: mdl-26101219

ABSTRACT

Centriole duplication occurs once per cell cycle in order to maintain control of centrosome number and ensure genome integrity. Polo-like kinase 4 (Plk4) is a master regulator of centriole biogenesis, but how its activity is regulated to control centriole assembly is unclear. Here we used gene editing in human cells to create a chemical genetic system in which endogenous Plk4 can be specifically inhibited using a cell-permeable ATP analogue. Using this system, we demonstrate that STIL localization to the centriole requires continued Plk4 activity. Most importantly, we show that direct binding of STIL activates Plk4 by promoting self-phosphorylation of the activation loop of the kinase. Plk4 subsequently phosphorylates STIL to promote centriole assembly in two steps. First, Plk4 activity promotes the recruitment of STIL to the centriole. Second, Plk4 primes the direct binding of STIL to the C terminus of SAS6. Our findings uncover a molecular basis for the timing of Plk4 activation through the cell cycle-regulated accumulation of STIL.


Subject(s)
Centrioles/metabolism , Intracellular Signaling Peptides and Proteins/metabolism , Microtubule-Associated Proteins/metabolism , Protein Serine-Threonine Kinases/metabolism , Adenosine Triphosphate/analogs & derivatives , Antibodies/immunology , Binding Sites/genetics , Binding Sites/immunology , Cell Cycle Checkpoints , Cell Division , Cell Line , Enzyme Activation , HEK293 Cells , Humans , Indazoles/pharmacology , Indoles/pharmacology , Intracellular Signaling Peptides and Proteins/genetics , Phosphorylation , Protein Binding , Protein Serine-Threonine Kinases/antagonists & inhibitors , Protein Structure, Tertiary , RNA Editing , RNA Interference , RNA, Small Interfering
5.
Proc Natl Acad Sci U S A ; 110(8): E736-45, 2013 Feb 19.
Article in English | MEDLINE | ID: mdl-23382207

ABSTRACT

Transactivating response region DNA binding protein (TDP-43) is the major protein component of ubiquitinated inclusions found in amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration (FTLD) with ubiquitinated inclusions. Two ALS-causing mutants (TDP-43(Q331K) and TDP-43(M337V)), but not wild-type human TDP-43, are shown here to provoke age-dependent, mutant-dependent, progressive motor axon degeneration and motor neuron death when expressed in mice at levels and in a cell type-selective pattern similar to endogenous TDP-43. Mutant TDP-43-dependent degeneration of lower motor neurons occurs without: (i) loss of TDP-43 from the corresponding nuclei, (ii) accumulation of TDP-43 aggregates, and (iii) accumulation of insoluble TDP-43. Computational analysis using splicing-sensitive microarrays demonstrates alterations of endogenous TDP-43-dependent alternative splicing events conferred by both human wild-type and mutant TDP-43(Q331K), but with high levels of mutant TDP-43 preferentially enhancing exon exclusion of some target pre-mRNAs affecting genes involved in neurological transmission and function. Comparison with splicing alterations following TDP-43 depletion demonstrates that TDP-43(Q331K) enhances normal TDP-43 splicing function for some RNA targets but loss-of-function for others. Thus, adult-onset motor neuron disease does not require aggregation or loss of nuclear TDP-43, with ALS-linked mutants producing loss and gain of splicing function of selected RNA targets at an early disease stage.


Subject(s)
Amyotrophic Lateral Sclerosis/genetics , Cell Nucleus/metabolism , DNA-Binding Proteins/genetics , Mutation , RNA Splicing , Amyotrophic Lateral Sclerosis/metabolism , Amyotrophic Lateral Sclerosis/physiopathology , Animals , DNA-Binding Proteins/metabolism , Mice , Mice, Transgenic , Real-Time Polymerase Chain Reaction , Ubiquitination
6.
Nat Neurosci ; 15(11): 1488-97, 2012 Nov.
Article in English | MEDLINE | ID: mdl-23023293

ABSTRACT

FUS/TLS (fused in sarcoma/translocated in liposarcoma) and TDP-43 are integrally involved in amyotrophic lateral sclerosis (ALS) and frontotemporal dementia. We found that FUS/TLS binds to RNAs from >5,500 genes in mouse and human brain, primarily through a GUGGU-binding motif. We identified a sawtooth-like binding pattern, consistent with co-transcriptional deposition of FUS/TLS. Depletion of FUS/TLS from the adult nervous system altered the levels or splicing of >950 mRNAs, most of which are distinct from RNAs dependent on TDP-43. Abundance of only 45 RNAs was reduced after depletion of either TDP-43 or FUS/TLS from mouse brain, but among these were mRNAs that were transcribed from genes with exceptionally long introns and that encode proteins that are essential for neuronal integrity. Expression levels of a subset of these were lowered after TDP-43 or FUS/TLS depletion in stem cell-derived human neurons and in TDP-43 aggregate-containing motor neurons in sporadic ALS, supporting a common loss-of-function pathway as one component underlying motor neuron death from misregulation of TDP-43 or FUS/TLS.


Subject(s)
Amyotrophic Lateral Sclerosis/metabolism , DNA-Binding Proteins/metabolism , Frontotemporal Dementia/metabolism , RNA Precursors/metabolism , RNA, Messenger/metabolism , RNA-Binding Protein FUS/metabolism , Adaptor Proteins, Signal Transducing , Amyotrophic Lateral Sclerosis/genetics , Amyotrophic Lateral Sclerosis/pathology , Animals , Autophagy-Related Proteins , Brain/metabolism , Brain/pathology , Carrier Proteins/genetics , Carrier Proteins/metabolism , Cell Cycle Proteins/genetics , Cell Cycle Proteins/metabolism , Cell Line, Transformed , DNA-Binding Proteins/deficiency , DNA-Binding Proteins/genetics , Excitatory Amino Acid Transporter 2/genetics , Excitatory Amino Acid Transporter 2/metabolism , Female , Frontotemporal Dementia/genetics , Frontotemporal Dementia/pathology , Gene Expression Profiling , Gene Expression Regulation/genetics , Histone-Lysine N-Methyltransferase/metabolism , Humans , Immunoprecipitation , Kv Channel-Interacting Proteins/metabolism , Membrane Proteins/metabolism , Mice , Mice, Inbred C57BL , Mice, Knockout , Motor Neurons/metabolism , Nerve Tissue Proteins/genetics , Nerve Tissue Proteins/metabolism , Neural Cell Adhesion Molecules/metabolism , Neural Stem Cells/metabolism , Neurofilament Proteins/metabolism , Oligonucleotide Array Sequence Analysis , Protein Binding/genetics , Protein Structure, Tertiary/genetics , RNA Precursors/genetics , RNA Splicing/genetics , RNA, Messenger/genetics , RNA, Small Interfering/genetics , RNA, Small Interfering/metabolism , RNA-Binding Protein FUS/deficiency , RNA-Binding Protein FUS/genetics , Shal Potassium Channels/metabolism , Spinal Cord/metabolism , Ubiquitin-Protein Ligases/metabolism , tau Proteins/genetics , tau Proteins/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...